American Health Packaging recalls Ranitidine Tablets, USP, 150 mg, 100 Tablets (10 tablets x 10 blister card), Rx Only, Packaged and Distributed by:
American Health Packaging recalls 150mg Ranitidine Tablets due to potential N-Nitrosodimethylamine (NDMA) levels above FDA limits. Affected lots expired by December 2020.
Lower-risk recall
CGMP Deviations: Potential N-Nitrosodimethylamine (NDMA) amounts above levels established by the FDA.
Contact the company & request your remedy
What happened, in plain English
American Health Packaging is recalling 150mg Ranitidine Tablets that may contain unsafe levels of NDMA. This chemical has been linked to potential health risks, so affected users should stop using the product. Read more at govinfonow.com/recall/37682-american-health-packaging-ranitidine-tablets-recall-potential-ndma-risk.
Source Summary by GovInfoNow · govinfonow.com/recall/37682-american-health-packaging-ranitidine-tablets-recall-potential-ndma-risk · Updated October 5, 2026 · FDA enforcement record: FDA #D-1003-2020
Cite this page
“American Health Packaging Ranitidine Tablets Recall: Potential NDMA Risk.” GovInfoNow, updated October 5, 2026. https://govinfonow.com/recall/37682-american-health-packaging-ranitidine-tablets-recall-potential-ndma-risk. Based on FDA recall #D-1003-2020 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1003-2020%22&limit=1).
Why it’s dangerous
The tablets may contain higher levels of N-Nitrosodimethylamine (NDMA) than FDA safety limits. NDMA is a potential carcinogen that could pose health risks with long-term use.
Who’s affected
People who have the recalled Ranitidine Tablets from American Health Packaging. Those with prescription orders for these specific lots are most at risk.
How to tell if you have this one
Check for the NDC carton number 60687-322-01 or unit dose card 60687-322-11. The affected lots include 179516, 179745 (exp 12/31/2019), 180712 (exp 02/29/2020), and others expiring by December 2020.
- Brand
American Health Packaging- Category
Drug
What to do — step by step
Check Product Details
Identify the NDC carton number (60687-322-01) and unit dose card (60687-322-11) on the packaging.
Stop Using Product
If you have the recalled lots, stop using the tablets immediately and contact your healthcare provider.
Questions people ask
What is the specific risk with these tablets?
The tablets may contain higher levels of N-Nitrosodimethylamine (NDMA) than FDA safety limits, which is a potential carcinogen.
Which lots are affected?
Affected lots include 179516, 179745 (exp 12/31/2019), 180712 (exp 02/29/2020), and others expiring by December 2020.
How do I know if I have the recalled product?
Check for NDC carton number 60687-322-01 or unit dose card 60687-322-11 on the packaging.
Contact American Health Packaging
We’ve drafted a message you can send American Health Packaging to request your refund or repair — edit it as you like.
Subject: Recall D-1003-2020 — American Health Packaging American Health Packaging Hello, I own a American Health Packaging that is covered by recall D-1003-2020 from American Health Packaging. I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Similar recalls
Keep exploring
From people who’ve dealt with this
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-1003-2020 (November 20, 2019) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1003-2020 to see it in context.
- Plain-language summary written by qwen3:4b on October 5, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.